Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha Mehta-Shah

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Ebiomedicine|July 31, 2019
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphomaJared M Andrews, Jennifer A Schmidt, Kenneth R Carson, et al.
Aesthetic Surgery Journal|November 9, 2022
Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome SequencingNeha Akkad, Rohan Kodgule, Eric J Duncavage, et al.
JAAD Case Reports|December 17, 2021
Alopecia areata after mogamulizumab treatmentNeel S Raval, Nora A Alexander, Karlee De Monnin, et al.
Case Reports in Oncology|January 13, 2023
Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with MyelopathySneha Poondru, Ancy Joseph, John C Harding, et al.
Hematological Oncology|June 13, 2023
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphomaLimei Poon, Laurence de Leval, Siok Bian Ng, et al.
Leukemia & Lymphoma|February 28, 2022
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experienceNeha Mehta-Shah, Nancy L Bartlett, Brad Kahl, et al.
European Journal of Dermatology : EJD|February 2, 2022
Scarring alopecia developing after mogamulizumab-associated rashNeel S Raval, Caroline K Snowden, Karlee S De Monnin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2024
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell LymphomasNicole Foley, Peter A Riedell, Nancy L Bartlett, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2023
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot StudiesDilan A Patel, Fei Wan, Kathryn Trinkaus, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
LAIR1 prevents excess inflammatory tissue damage in <i>S. aureus</i> skin infection and Cutaneous T-cell LymphomaHannah K Dorando, Evan C Mutic, Kelly L Tomaszewski, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Ebiomedicine|July 31, 2019
Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphomaJared M Andrews, Jennifer A Schmidt, Kenneth R Carson, et al.
Aesthetic Surgery Journal|November 9, 2022
Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome SequencingNeha Akkad, Rohan Kodgule, Eric J Duncavage, et al.
JAAD Case Reports|December 17, 2021
Alopecia areata after mogamulizumab treatmentNeel S Raval, Nora A Alexander, Karlee De Monnin, et al.
Case Reports in Oncology|January 13, 2023
Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with MyelopathySneha Poondru, Ancy Joseph, John C Harding, et al.
Hematological Oncology|June 13, 2023
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphomaLimei Poon, Laurence de Leval, Siok Bian Ng, et al.
Leukemia & Lymphoma|February 28, 2022
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experienceNeha Mehta-Shah, Nancy L Bartlett, Brad Kahl, et al.
European Journal of Dermatology : EJD|February 2, 2022
Scarring alopecia developing after mogamulizumab-associated rashNeel S Raval, Caroline K Snowden, Karlee S De Monnin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2024
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell LymphomasNicole Foley, Peter A Riedell, Nancy L Bartlett, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2023
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot StudiesDilan A Patel, Fei Wan, Kathryn Trinkaus, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
LAIR1 prevents excess inflammatory tissue damage in <i>S. aureus</i> skin infection and Cutaneous T-cell LymphomaHannah K Dorando, Evan C Mutic, Kelly L Tomaszewski, et al.
Pageof 9